Kestra Medical Technologies Ltd
KMTS25.470USD
+0.350+1.39%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
1.31BMarket Cap
LossP/E TTM
More Details of Kestra Medical Technologies Ltd Company
Kestra Medical Technologies, Ltd. is a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intelligent and connected. The Company has developed and is commercializing its Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. The Company's Cardiac Recovery System platform includes ASSURE WCD, which is a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). Its Cardiac Recovery System platform also includes fully integrated digital solutions and services such as the ASSURE patient application, Kestra CareStation remote patient data platform, Heart Alert Services, and ASSURE Assist services and ASSURE wearable ECG.
Kestra Medical Technologies Ltd Info
Ticker SymbolKMTS
Company nameKestra Medical Technologies Ltd
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)
Number of employees330
Security typeOrdinary Share
Fiscal year-endMar 06
Address3933 Lake Washington Blvd Ne
CityKIRKLAND
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code98033
Phone14252798002
Website
Ticker SymbolKMTS
IPO dateMar 06, 2025
CEOWebster (Brian Daniel)
Company Executives of Kestra Medical Technologies Ltd
Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
279.34K
-15000.00%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
94.42K
-10500.00%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
+21818.00%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-22059.00%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
+13120.00%
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Mr. Al Ford
Mr. Al Ford
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Jeffrey Schwartz
Mr. Jeffrey Schwartz
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Toby AuWerter
Mr. Toby AuWerter
Independent Director
Independent Director
--
--
Mr. Maxwell Bikoff
Mr. Maxwell Bikoff
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Brian Webster
Mr. Brian Webster
President, Chief Executive Officer, Founder, Director
President, Chief Executive Officer, Founder, Director
279.34K
-15000.00%
Ms. Traci S. Umberger
Ms. Traci S. Umberger
Chief Administrative Officer, General Counsel, Director
Chief Administrative Officer, General Counsel, Director
94.42K
-10500.00%
Dr. Elizabeth Kwo, M.D.
Dr. Elizabeth Kwo, M.D.
Independent Director
Independent Director
21.82K
+21818.00%
Mr. Vaseem Mahboob
Mr. Vaseem Mahboob
Chief Financial Officer
Chief Financial Officer
14.84K
-22059.00%
Mr. Conor Hanley
Mr. Conor Hanley
Independent Director
Independent Director
13.12K
+13120.00%
Ms. Debra Schotz
Ms. Debra Schotz
Senior Vice President - Marketing
Senior Vice President - Marketing
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: 22 hours ago
Updated: 22 hours ago
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Bain Capital Private Equity, LP
46.31%
Fidelity Management & Research Company LLC
7.45%
Endeavour Medtech Growth II LP
4.54%
Ally Bridge Group (HK) Limited
3.91%
T. Rowe Price Associates, Inc.
3.11%
Other
34.68%
Shareholders
Shareholders
Proportion
Bain Capital Private Equity, LP
46.31%
Fidelity Management & Research Company LLC
7.45%
Endeavour Medtech Growth II LP
4.54%
Ally Bridge Group (HK) Limited
3.91%
T. Rowe Price Associates, Inc.
3.11%
Other
34.68%
Shareholder Types
Shareholders
Proportion
Private Equity
46.31%
Investment Advisor
22.50%
Investment Advisor/Hedge Fund
12.46%
Corporation
4.54%
Venture Capital
2.82%
Hedge Fund
1.97%
Individual Investor
0.92%
Research Firm
0.20%
Sovereign Wealth Fund
0.14%
Other
8.16%
Institutional Shareholding
Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
171
50.34M
86.28%
+869.96K
2025Q3
138
48.47M
94.21%
+1.86M
2025Q2
93
49.39M
96.22%
+48.70M
2025Q1
74
47.97M
93.41%
+47.97M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Bain Capital Private Equity, LP
27.02M
46.31%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.35M
7.45%
+1.51M
+53.18%
Sep 30, 2025
Endeavour Medtech Growth II LP
2.65M
4.54%
+2.65M
--
Mar 31, 2025
Ally Bridge Group (HK) Limited
2.28M
3.91%
--
--
Sep 30, 2025
T. Rowe Price Associates, Inc.
1.82M
3.11%
+825.66K
+83.35%
Sep 30, 2025
Omega Fund Management, LLC
1.65M
2.82%
--
--
Sep 30, 2025
AllianceBernstein L.P.
1.49M
2.56%
+179.88K
+13.71%
Sep 30, 2025
The Vanguard Group, Inc.
752.15K
1.29%
-10.34K
-1.36%
Sep 30, 2025
Brown Advisory
1.26M
2.16%
+679.34K
+117.12%
Sep 30, 2025
Eventide Asset Management, LLC
1.20M
2.06%
+143.81K
+13.56%
Sep 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Global X HealthTech ETF
0.43%
Goldman Sachs Innovate Equity ETF
0.13%
Fidelity Blue Chip Growth ETF
0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.04%
iShares Russell 2000 Growth ETF
0.02%
Fidelity Nasdaq Composite Index ETF
0.01%
Global X Russell 2000 ETF
0.01%
Schwab U.S. Small-Cap ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Morningstar Small-Cap ETF
0.01%
View more
Global X HealthTech ETF
Proportion0.43%
Goldman Sachs Innovate Equity ETF
Proportion0.13%
Fidelity Blue Chip Growth ETF
Proportion0.06%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.02%
Fidelity Nasdaq Composite Index ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Schwab U.S. Small-Cap ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Morningstar Small-Cap ETF
Proportion0.01%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
